Back to IMRXView full pipeline
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
0 competitors in Advanced Solid Tumor (Phase 1)
View Full LandscapeDrug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
AtebimetinibPhase 3
Pancreatic Cancer
mGnPPhase 3
Pancreatic Cancer
IMM-1-104 + pembrolizumab (Treatment Group E)Phase 2
Advanced Solid Tumor
IMM-1-104 + modified FOLFIRINOX (Treatment Group C)Phase 2
Advanced Solid Tumor
IMM-1-104 + modified Gemcitabine/nab-Paclitaxel (Treatment Group B)Phase 2
Advanced Solid Tumor
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
